Carlsbad, CA, United States of America

Zhengrong Yu

This inventor holds 7 USPTO granted patents and 8 published patent applications and 6 EPO patents. Top assignees: Ionis Pharmaceuticals, Inc., Isis Pharmaceuticals, Inc., Carlsbad. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhengrong Yu. Retrieved from https://idiyas.com/inventor/zhengrong-yu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 71.4

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovator Zhengrong Yu: Pioneering Advances in Apolipoprotein Research

Introduction

Zhengrong Yu is a prominent inventor based in Carlsbad, CA, recognized for his significant contributions to the field of biotechnology. With a total of seven patents to his name, he is particularly noted for his research on apolipoproteins, which play a crucial role in the regulation of lipid metabolism and cardiovascular health.

Latest Patents

Yu's latest patents focus on modulating apolipoprotein (A) expression through oligomeric compounds. These innovative compounds are designed to target apolipoprotein (a) [apo(a)], a significant factor in various diseases. The patents describe the use of conjugate groups, particularly N-Acetylgalactosamine, to decrease levels of apo(a). This targeted approach aims to treat, prevent, or ameliorate conditions related to apo(a) and lipoprotein(a) [Lp(a)], including inflammatory, cardiovascular, and metabolic diseases. The conjugated oligomeric compounds developed by Yu provide new therapeutic strategies for individuals suffering from these health issues.

Career Highlights

Zhengrong Yu has held key positions in several esteemed companies throughout his career, including Ionis Pharmaceuticals, Inc. and International Business Machines Corporation (formerly Isis Pharmaceuticals, Inc.). His work in these organizations has been pivotal in advancing drug development, particularly in the realm of genetic and metabolic disorders.

Collaborations

Throughout his career, Yu has collaborated with notable professionals such as Richard S. Geary and Nicholas J. Viney. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of knowledge, enabling Yu to develop groundbreaking solutions in biomedical research.

Conclusion

Zhengrong Yu’s contributions to biotechnology, particularly concerning apolipoproteins, solidify his status as an influential inventor. His innovative patents and collaborations underscore his commitment to advancing medical science and enhancing the understanding of complex diseases, paving the way for potential new treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…